Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Analysis of fluid-phase mediators.

Literature DB >> 12361360

Analysis of fluid-phase mediators.

M M Kelly¹, V Keatings, R Leigh, C Peterson, J Shute, P Venge, R Djukanović.

Abstract

Mesh：

Substances：
Inflammation Mediators

Year: 2002 PMID： 12361360

Source DB: PubMed Journal: Eur Respir J Suppl ISSN： 0904-1850

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

1. Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations.

Authors: Eric W Alton; Homer A Boushey; Holger Garn; Francis H Green; Michael Hodges; Richard J Martin; Robert D Murdoch; Harald Renz; Stephen B Shrewsbury; Rosanne Seguin; Graham Johnson; Joel D Parry; Jeff Tepper; Paolo Renzi; Joy Cavagnaro; Nicolay Ferrari
Journal: Nucleic Acid Ther Date: 2012-07-18 Impact factor: 5.486

2. Diagnostic value of sputum adenosine deaminase (ADA) level in pulmonary tuberculosis.

Authors: Fariba Binesh; Hadi Jalali; Mohammad Reza Zare; Farhad Behravan; Arefeh Dehghani Tafti; Fatemah Behnaz; Mohammad Tabatabaee; Seyed Hossein Shahcheraghi
Journal: Germs Date: 2016-06-01

3. Methodology for Sputum Induction and Laboratory Processing.

Authors: Julien Guiot; Sophie Demarche; Monique Henket; Virginie Paulus; Sophie Graff; Florence Schleich; Jean-Louis Corhay; Renaud Louis; Catherine Moermans
Journal: J Vis Exp Date: 2017-12-17 Impact factor: 1.355

4. Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

Authors: Vandana Gupta; Antonia Banyard; Aoibheann Mullan; Srividya Sriskantharajah; Thomas Southworth; Dave Singh
Journal: Br J Clin Pharmacol Date: 2015-05 Impact factor: 4.335

5. In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.

Authors: Andreas Hector; Matthias Kappler; Matthias Griese
Journal: Mediators Inflamm Date: 2010-06-16 Impact factor: 4.711

Analysis of fluid-phase mediators.

1. Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations.

2. Diagnostic value of sputum adenosine deaminase (ADA) level in pulmonary tuberculosis.

3. Methodology for Sputum Induction and Laboratory Processing.

4. Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

5. In vitro inhibition of neutrophil elastase activity by inhaled anti-Pseudomonas antibiotics used in cystic fibrosis patients.

Review 6. Sputum biomarkers of inflammation in cystic fibrosis lung disease.

7. Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs.

8. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease.

9. Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.

10. Sputum IgE and cytokines in asthma: relationship with sputum cellular profile.